Literature DB >> 19424557

Coxsackieviruses infection in northern Taiwan--epidemiology and clinical characteristics.

Feng-Bin Yen1, Luan-Yin Chang, Chuan-Liang Kao, Ping-Ing Lee, Chun-Min Chen, Chin-Yun Lee, Pei-Lan Shao, Shu-Chien Wang, Chun-Yi Lu, Li-Min Huang.   

Abstract

BACKGROUND AND
PURPOSE: The epidemiology of coxsackievirus has rarely been investigated in Taiwan. This study was performed to ascertain the epidemiological and clinical characteristics of coxsackievirus infections in Taiwan.
METHODS: 457 patients treated at a medical center in northern Taiwan who were positive for coxsackievirus were enrolled in this retrospective study. Patients' medical charts were reviewed for clinical diagnosis, physical examination, laboratory findings, and clinical manifestations.
RESULTS: Three serotypes of coxsackievirus A (A9, 5.3%; A10, 7.2%; A16, 87.5%) were identified among 265 patients, 27.4% of whom were admitted to hospital. The mean (+/- standard deviation [SD]) duration of fever and hospital stay was 2.6 +/- 0.5 days and 4.0 +/- 2.1 days, respectively. Complications were noted in 14 patients (5.3%), all of which involved the central nervous system (CNS). All 6 serotypes of coxsackievirus B (B1, 2.6%; B2, 7.8%; B3, 55.7%; B4, 2.1%; B5, 12.5%; B6, 1.0%; non-typable, 18.2%) were identified in 192 patients, 45.3% of whom were admitted to hospital. The mean (+/- SD) duration of fever and hospital stay was 4.1 +/- 1.0 and 3.4 +/- 0.9 days, respectively. Thirty seven patients (19.3%) had complications, including 34 with CNS involvement. Patients with coxsackievirus B infection had higher hospital admission rates (p < 0.001), more CNS involvement (p < 0.001), and longer fever duration (p < 0.001) than those with coxsackievirus A infection. Patients with coxsackievirus A infection tended to have more skin manifestations (p < 0.001) and oral ulcers (p < 0.001).
CONCLUSIONS: The most common serotypes were coxsackieviruses A16 and B3. Patients with coxsackievirus B infection were more likely to be admitted to hospital, had longer fever duration, and more CNS involvement than patients with coxsackievirus A infection.

Entities:  

Mesh:

Year:  2009        PMID: 19424557

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  20 in total

1.  Molecular identification and analysis of nonserotypeable human enteroviruses.

Authors:  Fei Zhou; Fanrong Kong; Kenneth McPhie; Mala Ratnamohan; Gwendolyn L Gilbert; Dominic E Dwyer
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

2.  Disruption of MDA5-Mediated Innate Immune Responses by the 3C Proteins of Coxsackievirus A16, Coxsackievirus A6, and Enterovirus D68.

Authors:  Yajuan Rui; Jiaming Su; Hong Wang; Junliang Chang; Shaohua Wang; Wenwen Zheng; Yong Cai; Wei Wei; James T Gordy; Richard Markham; Wei Kong; Wenyan Zhang; Xiao-Fang Yu
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

3.  Type I Interferons Triggered through the Toll-Like Receptor 3-TRIF Pathway Control Coxsackievirus A16 Infection in Young Mice.

Authors:  Juhao Yang; Chunfu Yang; Nining Guo; Kai Zhu; Kaiming Luo; Na Zhang; Hui Zhao; Ying Cui; Lei Chen; Hongyang Wang; Jun Gu; Baoxue Ge; Cheng-Feng Qin; Qibin Leng
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

4.  Complete genome sequence analysis of two human coxsackievirus A9 strains isolated in Yunnan, China, in 2009.

Authors:  Jiansheng Liu; Yanju Zhu; Yue Pan; Zhengling Liu; Chen Guo; Shaohui Ma
Journal:  Virus Genes       Date:  2015-02-14       Impact factor: 2.332

5.  Seroepidemiology of coxsackievirus B5 in infants and children in Jiangsu province, China.

Authors:  Fan Gao; Lianlian Bian; Xiaotian Hao; Yalin Hu; Xin Yao; Shiyang Sun; Pan Chen; Ce Yang; Ruixiao Du; Jingxin Li; Fengcai Zhu; Qunying Mao; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2017-11-27       Impact factor: 3.452

6.  Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014.

Authors:  Xin Yao; Lian-Lian Bian; Wei-Wei Lu; Jing-Xin Li; Qun-Ying Mao; Yi-Ping Wang; Fan Gao; Xing Wu; Qiang Ye; Xiu-Ling Li; Feng-Cai Zhu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2016-10-21       Impact factor: 3.452

7.  Detection of human enteroviruses and parechoviruses as part of the national enterovirus surveillance in the Netherlands, 1996-2011.

Authors:  S M G van der Sanden; M P G Koopmans; H G A M van der Avoort
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-06-19       Impact factor: 3.267

8.  Hepatitis and Encephalitis due to Coxsackie Virus A9 in an Adult.

Authors:  Brigitte Moreau; Clare Bastedo; Rene P Michel; Peter Ghali
Journal:  Case Rep Gastroenterol       Date:  2011-10-10

9.  Clinical features and phylogenetic analysis of Coxsackievirus A9 in Northern Taiwan in 2011.

Authors:  Yi-Chuan Huang; Ying-Hsia Chu; Ting-Yu Yen; Wen-Chan Huang; Li-Min Huang; Ai-Ling Cheng; Hurng-Yi Wang; Luan-Yin Chang
Journal:  BMC Infect Dis       Date:  2013-01-24       Impact factor: 3.090

10.  Induction of cytopathic effect and cytokines in coxsackievirus B3-infected murine astrocytes.

Authors:  Jun Zeng; Gefei Wang; Weizhong Li; Dangui Zhang; Xiaoxuan Chen; Gang Xin; Zhiwu Jiang; Kangsheng Li
Journal:  Virol J       Date:  2013-05-21       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.